Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

ent of metastatic breast cancer and is also in Phase 2 studies for the treatment of lung and brain cancers. In anti-infectives, Amikacin Inhale is in Phase 3 studies conducted by Bayer Healthcare as an adjunctive treatment for intubated and mechanically ventilated patients with Gram-negative pneumonia. Additional late-stage development products that leverage Nektar's proprietary technology platform include Baxter's BAX 855, a longer-acting rFVIII program, which is in Phase 3 clinical development for patients with hemophilia A.

Nektar's technology has enabled eight approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia.

Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com

*Sources: Bell TJ et. al. Pain Med 2009;10(1):35-42, Hess B et. al. Eur J Intern Med 2011;22(5):527-531, Rosti G et. al Eur Rev Med Pharmacol Sci. 2010;14(12):1045-1050. Galvez R et. al. Aten Primaria 2014;46(1):32-39, Droney J et. al. Support Care Cancer 2008;16(5):453-459.

Movantik is a trademark of AstraZeneca.

Cautionary Note Regarding Forward-Looking StatementsThis press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "expect," "believe," "should," "may," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the potential regulatory approval of Movantik&
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... July 4, 2015 Añadir ... quimioterapia de primera línea para pacientes con cáncer ... extiende la supervivencia libre de progresión en ese ... metastásico no resecable (mCRC) que se ha propagado ... la supervivencia libre de progresión (PFS) en el ...
(Date:7/4/2015)... 4, 2015 De ... chemotherapie voor patiënten met niet-resectabele uitgezaaide colorectale ... progressievrije overleving in dat orgaan. ... (mCRC) die alleen binnen de lever is ... overleving (PFS) in de lever dankzij de ...
(Date:7/4/2015)... , July 4, 2015 ... for patients with unresectable metastatic colorectal cancer in ... that organ Patients with unresectable metastatic ... the liver experienced the greatest improvement in Progression-Free ... of SIR-Spheres Y-90 resin microspheres to a current ...
Breaking Medicine Technology:El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 2El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 3El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 4El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 5Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4
... , LOS ANGELES , June 1 One minute ... their two dogs. The next, they had shattered legs and pelvises and one of ... horrifying impact, leaving them to put the pieces of their lives back together. ... In the nearly two years since ...
... CareFusion (NYSE: CFN ), a leading, ... Closed Loop Controller of Inspired Oxygen system or "CLiO2™," the ... the oxygen level in the blood within a safe range ... an enhancement to the CareFusion AVEA™ ventilator, one of the ...
Cached Medicine Technology:The SCOOTER Store Donates Scooter to Hit-and-Run Accident Victim 2The SCOOTER Store Donates Scooter to Hit-and-Run Accident Victim 3CareFusion Launches First Automatic Oxygen Controller to Improve Care for Newborns Needing Mechanical Ventilation 2CareFusion Launches First Automatic Oxygen Controller to Improve Care for Newborns Needing Mechanical Ventilation 3
(Date:7/3/2015)... Greenville, SC (PRWEB) , ... ... ... Society has announced the sessions and speaker lineup for its 2015 ... nursing, taking place August 6-8, 2015 at the Renaissance Orlando at SeaWorld ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... healthcare providers, has been retained to lead a national chief nursing officer ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:7/3/2015)... ... ... Jennifer Renee Hanes, DO is the new Medical Director of its Sienna Plantation ... emergency rooms in the United States. , “We are excited to welcome Dr. Hanes ... Director of First Choice Emergency Room, Dr. James M. Muzzarelli. , Dr. Hanes ...
(Date:7/3/2015)... ... July 03, 2015 , ... Every year, One-to-1 Fitness ... where they provide members of the Red Deer community with free fitness training and ... fitness training, games, food, events and entertainment raised thousands of charity dollars and ended ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to ... the 19th sweetFrog store located in the Lone Star State. The premium frozen yogurt ... in 2014. , The store, which opened July 1 at Duke’s Travel Plaza, is ...
Breaking Medicine News(10 mins):Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... your own back, have a loved one take a look, study ... delivers a lifesaving message to older men about the potentially deadly ... back, have a loved one take a look, and if there,s ... why it is that when a doctor finds a melanoma, it ...
... Nicole Lauzon and Dr. Steven Laviolette of the Schulich ... Western Ontario has found key processes in the brain ... how we form memories of them. A lack of ... beneath such conditions as Schizophrenia and Post-Traumatic Stress Disorder ...
... Mark Leventhal, Esq., the Founder and President of Leventhal Consulting, ... executive weight loss consulting service for attorneys by an attorney, ... 1055 West 7th Street, 27th Floor, today. His presentation ... Mark Leventhal will be talking about the importance of losing ...
... Presented at the 2009 Experimental Biology ConferenceOMAHA, Neb., April ... shows people who ate Healthy Choice(R) really did get ... 18 pounds - all as fat - trimmed their ... by 12 points. Leading cardiologist Dr. James Rippe, founder ...
... Connectivity with Clearinghouses, Strategic Trading Partners and Bill ... CONCORD, Calif., April 20 Jopari Solutions, ... EDI Gateway services, is further expanding its connectivity ... enables Jopari to position mission critical eBill connectivity ...
... The search for the cause of an inherited form ... important information about how the cancer develops and potentially ... , The finding by researchers at Washington University School ... in Washington, D.C., the International Pleuropulmonary Blastoma Registry at ...
Cached Medicine News:Health News:Older Men Need to Take Closer Look for Melanomas 2Health News:Older Men Need to Take Closer Look for Melanomas 3Health News:Controlling our brain's perception of emotional events 2Health News:Mark Leventhal Speaks at the Los Angeles County Bar Association 2Health News:New Research Shows Healthy Choice Lives Up To Its Name 2Health News:New Research Shows Healthy Choice Lives Up To Its Name 3Health News:Jopari Further Expands Nationwide Medical Billing Network Connectivity for Workers' Comp and Auto Providers and Payers 2Health News:Jopari Further Expands Nationwide Medical Billing Network Connectivity for Workers' Comp and Auto Providers and Payers 3Health News:Genetic source of rare childhood cancer found; gene is implicated in other cancers 2Health News:Genetic source of rare childhood cancer found; gene is implicated in other cancers 3
... family of infrared laser photocoagulators includes the ... diode lasers serve as a single laser ... require no regular maintenance or special electrical/cooling, ... design. The OcuLight SLx is now available ...
... is the least expensive of the series. It has ... central area of the cornea. The model comes with ... a picture of a patients corneal endothelium, you simply ... on the chin rest. The left side of the ...
... permeable contact lenses used for corneal refractive ... (myopia). The patient wears the lenses overnight ... During the day, nearsightedness is corrected or ... RG contact lenses apply slight pressure to ...
... the major challenges to operating your ... market fee for each procedure includes:, ... requirements., Board Certified Nuclear Medicine Technologist., ... Hot Lab Equipment and Accessories., All ...
Medicine Products: